CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-15 | Tulipano Stephen J CFO | Grant or award · Restricted Stock Unit (RSU) | +52,400 | 52,400 | ||
| 2023-03-15 | Ticho Barry Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +78,600 | 78,600 | ||
| 2023-03-15 | Ticho Barry Chief Medical Officer | Grant or award · Restricted Stock Unite (RSU) | +52,400 | 52,400 | ||
| 2023-03-15 | Nash Huw M. COO & CBO | Grant or award · Employee Stock Option (Right to Buy) | +78,600 | 78,600 | ||
| 2023-03-15 | Nash Huw M. COO & CBO | Grant or award · Restricted Stock Unit (RSU) | +52,400 | 52,400 | ||
| 2023-03-15 | Kaye Edward M. MD CEO | Grant or award · Employee Stock Option (Right to Buy) | +213,000 | 213,000 | ||
| 2023-03-15 | Kaye Edward M. MD CEO | Grant or award · Restricted Stock Unit (RSU) | +142,000 | 142,000 | ||
| 2023-02-06 | Ticho Barry Chief Medical Officer | Sale | −9,235 | $10.02 | $92K | 111,725 |
| 2023-02-03 | Ticho Barry Chief Medical Officer | Sale | −3,763 | $10.03 | $38K | 120,960 |
| 2023-02-02 | Ticho Barry Chief Medical Officer | Sale | −267 | $10.00 | $3K | 124,723 |
| 2023-02-01 | Ticho Barry Chief Medical Officer | Sale | −5,705 | $10.02 | $57K | 124,990 |
| 2023-01-31 | Ticho Barry Chief Medical Officer | Sale | −200 | $10.00 | $2K | 130,695 |
| 2022-12-07 | Tulipano Stephen J CFO | Grant or award · Employee Stock Option (Right to Buy) | +62,000 | 62,000 | ||
| 2022-12-07 | Ticho Barry Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +62,000 | 62,000 | ||
| 2022-12-07 | Nash Huw M. COO & CBO | Grant or award · Employee Stock Option (Right to Buy) | +62,000 | 62,000 | ||
| 2022-12-07 | Kaye Edward M. MD CEO | Grant or award · Employee Stock Option (Right to Buy) | +167,050 | 167,050 | ||
| 2022-06-07 | LEVIN ARTHUR A Director | Grant or award · Director Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2022-06-07 | Menzel Garry E Director | Grant or award · Director Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2022-06-07 | Burstein Jennifer Director | Grant or award · Director Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2022-06-07 | Harrison Seth Loring Director | Grant or award · Director Stock Option (Right to Buy) | +21,000 | 21,000 |
Page 21 of 24 · 461 trades